Laylay, Winde .
HRN: 01-78-60 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2026
CEFUROXIME 500MG (TAB)
01/04/2026
01/11/2026
PO
500mg
BID
S/p Nsvd
Waiting Final Action
01/07/2026
CEFUROXIME 500MG (TAB)
01/07/2026
01/14/2026
PO
1 Tab
Q8h
UTI
Waiting Final Action
01/07/2026
CEFUROXIME 500MG (TAB)
01/07/2026
01/14/2026
PO
1 Tab
BID
UTI
Waiting Final Action